EUVIMEDEUVIMED entdecken
Vergleichsstudie

Higher risk of platelet engraftment failure and chronic graft‐versus‐host disease after allogeneic haematopoietic stem cell transplantation following chimeric antigen receptor T‐cell therapy compared to chemotherapy: A propensity score‐matched analysis

Luxin Yang, Xiaoyu Lai, Lizhen Liu, Jimin Shi, Yanmin Zhao, Jian Yu, Yibo Wu, Huarui Fu, Yongxian Hu, Mingming Zhang, He Huang iD, Yi Luo iD

British Journal of Haematology · 2025

DOI: 10.1111/bjh.20180 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift British Journal of Haematology, 2025. Verfasst von Luxin Yang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Immunotherapy, Adoptive, Blood Platelets. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Allogeneic haematopoietic stem cell transplantation (allo‐HSCT) has been reported to further sustain long‐term leukaemia‐free survival following chimeric antigen receptor T‐cell (CAR‐T) therapy. It remains unclear whether bridging CAR‐T to allo‐HSCT results in higher treatment‐related toxicity and mortality. We conducted a retrospective study to compare outcomes between allo‐HSCT after CAR‐T or conventional chemotherapy. After propensity score matching, 62 patients with prior CAR‐T therapy and 124 patients with chemotherapy were ultimately included. Patients in the CAR‐T cohort had a longer duration time from diagnosis to transplant ( p < 0.001) and more advanced disease status before HSCT ( p < 0.001) than that of the chemotherapy cohort. Patients with prior CAR‐T cell therapy had a lower 28‐day platelet engraftment rates [Hazard Rate (HR) = 1.38, 95% Confidence Interval (CI), 1.02–1.87, p = 0.037]. Multivariate analysis revealed that CAR‐T therapy increased the risk of moderate to severe chronic graft‐versus‐host disease (cGVHD) (HR = 2.5, 95% CI, 1.01–6.19, p = 0.048). Compared with patients in the chemotherapy cohort, those in the CAR‐T cell cohort experienced a higher incidence of transplantation‐associated thrombotic microangiopathy (6.5% vs. 0.8%, p = 0.03) and probable/possible invasive fungal disease (10.0% vs. 3.3%, p = 0.08). The relapse rate, non‐relapse mortality, and survival were comparable between cohorts. Caution should be exercised in allo‐HSCT following CAR‐T therapy because of the higher risk of platelet engraftment failure and cGVHD compared to chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationImmunotherapy, AdoptiveBlood PlateletsHumansMaleFemaleMiddle AgedAdultRetrospective StudiesPropensity ScoreChronic DiseaseTransplantation, HomologousAgedAdolescentReceptors, Chimeric AntigenYoung AdultHematologic Neoplasms

Stichwörter der Autor:innen

allogeneic haematopoietic stem cell transplantationchimeric antigen receptor T‐cell therapypropensity score‐matched analysistreatment‐related toxicities

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Bone Marrow Transplantation Center of the First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China.
  • Institute of Hematology, Zhejiang University, Hangzhou, China.
  • Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China.

ORCID-Profile: He Huang, Yi Luo

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yang, L., Lai, X., Liu, L., Shi, J., Zhao, Y., Yu, J., Wu, Y., Fu, H., Hu, Y., Zhang, M., Huang, H., & Luo, Y. (2025). Higher risk of platelet engraftment failure and chronic graft‐versus‐host disease after allogeneic haematopoietic stem cell transplantation following chimeric antigen receptor T‐cell therapy compared to chemotherapy: A propensity score‐matched analysis. British Journal of Haematology. https://doi.org/10.1111/bjh.20180

Vancouver

Yang L, Lai X, Liu L, Shi J, Zhao Y, Yu J, et al. Higher risk of platelet engraftment failure and chronic graft‐versus‐host disease after allogeneic haematopoietic stem cell transplantation following chimeric antigen receptor T‐cell therapy compared to chemotherapy: A propensity score‐matched analysis. British Journal of Haematology. 2025. doi:10.1111/bjh.20180

BibTeX
@article{Yang2025,
  author = {Yang, Luxin and Lai, Xiaoyu and Liu, Lizhen and Shi, Jimin and Zhao, Yanmin and Yu, Jian and Wu, Yibo and Fu, Huarui and Hu, Yongxian and Zhang, Mingming and Huang, He and Luo, Yi},
  title = {Higher risk of platelet engraftment failure and chronic graft‐versus‐host disease after allogeneic haematopoietic stem cell transplantation following chimeric antigen receptor T‐cell therapy compared to chemotherapy: A propensity score‐matched analysis},
  journal = {British Journal of Haematology},
  year = {2025},
  doi = {10.1111/bjh.20180}
}
Kostenlos starten →